Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearance
{{output}}
Anemia is one of the most prevalent systemic complications in patients with cancer, substantially impairing quality of life and limiting the safe administration of cytoreductive therapies. Despite its clinical significance, the mechanisms by which tumors disru... ...